113 related articles for article (PubMed ID: 8198378)
1. Thalassemia: pathophysiology of red cell changes.
Schrier SL
Annu Rev Med; 1994; 45():211-8. PubMed ID: 8198378
[TBL] [Abstract][Full Text] [Related]
2. A normal beta-globin allele as a modifier gene ameliorating the severity of alpha-thalassemia in mice.
Leder A; Wiener E; Lee MJ; Wickramasinghe SN; Leder P
Proc Natl Acad Sci U S A; 1999 May; 96(11):6291-5. PubMed ID: 10339580
[TBL] [Abstract][Full Text] [Related]
3. Increased Expression of α-Hemoglobin Stabilizing Protein (AHSP) mRNA in Erythroid Precursor Cells Isolated from β-Thalassemia Patients Treated with Sirolimus (Rapamycin).
Zurlo M; Zuccato C; Cosenza LC; Gamberini MR; Finotti A; Gambari R
J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731008
[No Abstract] [Full Text] [Related]
4. Identification of a rare [
Bellad A; Rangiah K; Sathe G; Dey G; Appadorai PK; Lokanatha H; Murthy PR; Gowdra A; Pandey A
Proteomics; 2024 Jan; ():e2300495. PubMed ID: 38212249
[TBL] [Abstract][Full Text] [Related]
5. Dual α-globin and truncated EPO receptor knockin restores hemoglobin production in α-thalassemia-derived red blood cells.
Chu SN; Soupene E; Wienert B; Yin H; Sharma D; McCreary T; Jia K; Homma S; Hampton JP; Gardner JM; Conklin BR; MacKenzie TC; Porteus MH; Cromer MK
bioRxiv; 2024 May; ():. PubMed ID: 38766216
[TBL] [Abstract][Full Text] [Related]
6. Molecular Basis and Genetic Modifiers of Thalassemia.
Tesio N; Bauer DE
Hematol Oncol Clin North Am; 2023 Apr; 37(2):273-299. PubMed ID: 36907603
[TBL] [Abstract][Full Text] [Related]
7. Hemolysis-associated pulmonary hypertension in thalassemia.
Morris CR; Kuypers FA; Kato GJ; Lavrisha L; Larkin S; Singer T; Vichinsky EP
Ann N Y Acad Sci; 2005; 1054():481-5. PubMed ID: 16339702
[TBL] [Abstract][Full Text] [Related]
8. Production and Characterization of K562 Cellular Clones Hyper-Expressing the Gene Encoding α-Globin: Preliminary Analysis of Biomarkers Associated with Autophagy.
Zurlo M; Gasparello J; Cosenza LC; Breveglieri G; Papi C; Zuccato C; Gambari R; Finotti A
Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980829
[TBL] [Abstract][Full Text] [Related]
9. Modulators of erythropoiesis: emerging therapies for hemoglobinopathies and disorders of red cell production.
Breda L; Rivella S
Hematol Oncol Clin North Am; 2014 Apr; 28(2):375-86. PubMed ID: 24589272
[TBL] [Abstract][Full Text] [Related]
10. Mitoxantrone ameliorates ineffective erythropoiesis in a β-thalassemia intermedia mouse model.
Zhang H; Liu R; Fang Z; Nie L; Ma Y; Sun F; Mei J; Song Z; Ginzburg YZ; Liu J; Chen H
Blood Adv; 2024 Jun; ():. PubMed ID: 38861356
[TBL] [Abstract][Full Text] [Related]
11. Genetic and Epigenetic Therapies for β-Thalassaemia by Altering the Expression of α-Globin Gene.
Mettananda S
Front Genome Ed; 2021; 3():752278. PubMed ID: 34713267
[TBL] [Abstract][Full Text] [Related]
12. Classical meets malignant hematology: a case of acquired εγδβ-thalassemia in clonal hematopoiesis.
Piehler AP; Truger M; Kozik JH; Weissmann S; Schwonzen M; Meggendorfer M; Kern W; Haferlach T; Hoermann G; Haferlach C
Haematologica; 2024 Mar; ():. PubMed ID: 38497167
[TBL] [Abstract][Full Text] [Related]
13. Metabolic regulation of erythrocyte development and disorders.
Lyu J; Ni M; Weiss MJ; Xu J
Exp Hematol; 2024 Mar; 131():104153. PubMed ID: 38237718
[TBL] [Abstract][Full Text] [Related]
14. A Moonlighting Job for alpha-Globin in Blood Vessels.
Abbineni P; Baid S; Weiss MJ
Blood; 2024 Jun; ():. PubMed ID: 38848504
[TBL] [Abstract][Full Text] [Related]
15. NOVEL THERAPEUTIC APPROACHES IN THALASSEMIAS, SICKLE CELL DISEASE AND OTHER RED CELL DISORDERS.
Pinto VM; Mazzi F; De Franceschi L
Blood; 2024 May; ():. PubMed ID: 38820588
[TBL] [Abstract][Full Text] [Related]
16. Natural Anticoagulant Protein Levels in Patients With Beta-Thalassemia Major: A Case-Control Study.
Ahmadi A; Hosseini S; Dorgalaleh A; Hassani S; Tabibian S; Tavasoli B; Shabannezhad A; Taheri M; Shams M
J Hematol; 2024 Apr; 13(1-2):23-28. PubMed ID: 38644988
[TBL] [Abstract][Full Text] [Related]
17. Keith J, Christakopoulos GE, Fernandez AG, et al. Loss of miR-144/451 alleviates β-thalassemia by stimulating ULK1-mediated autophagy of free α-globin. Blood. 2023;142(10):918-932.
Blood; 2024 Jan; 143(4):377. PubMed ID: 38270940
[No Abstract] [Full Text] [Related]
18. Is RBC discrimination index suitable for differentiating between α- and β- thalassemias?
Gorakshakar AC; Colah RB
Indian J Hum Genet; 2011 Sep; 17(3):115-6. PubMed ID: 22345979
[No Abstract] [Full Text] [Related]
19. The Correlation Between Ineffective Erythropoiesis Biomarkers and Development of Extramedullary Hematopoiesis in Patients with Thalassemia.
Chansai S; Yamsri S; Fucharoen S; Fucharoen G; Teawtrakul N
Mediterr J Hematol Infect Dis; 2022; 14(1):e2022052. PubMed ID: 35865404
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
